Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2023

May 15, 2023

BUY
$6.7 - $24.21 $69,680 - $251,784
10,400 New
10,400 $252,000
Q1 2022

May 16, 2022

SELL
$3.4 - $7.88 $73,780 - $170,996
-21,700 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$5.59 - $7.39 $121,303 - $160,363
21,700 New
21,700 $125,000
Q3 2021

Nov 12, 2021

SELL
$5.66 - $8.33 $71,882 - $105,791
-12,700 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$6.71 - $11.04 $85,217 - $140,208
12,700 New
12,700 $107,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.